+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Molecular Diagnostics: Technologies and Global Markets - Product Thumbnail Image

Molecular Diagnostics: Technologies and Global Markets

  • Report
  • April 2022
  • 204 Pages
  • Global
From
Plasma Fractionation Market 2024-2028 - Product Thumbnail Image

Plasma Fractionation Market 2024-2028

  • Report
  • December 2023
  • 163 Pages
  • Global
From
From
From
Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1000 Pages
  • Global
From
Primary Immunodeficiency Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Immunodeficiency Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 136 Pages
  • Global
From
From
From
From
Immunoglobulins: Global Market Outlook - Product Thumbnail Image

Immunoglobulins: Global Market Outlook

  • Report
  • March 2023
  • 64 Pages
  • Global
From
From
From
Immunoglobulins Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunoglobulins Market - Global Outlook & Forecast 2021-2026

  • Report
  • September 2021
  • 262 Pages
  • Global
From
Loading Indicator